This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DEH vs. ESTA, AVNS, SMTI, INGN, LAKE, AVR, ZJYL, NTRB, MLSS, and APTShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Anteris Technologies Global (AVR), Jin Medical International (ZJYL), Nutriband (NTRB), Milestone Scientific (MLSS), and Alpha Pro Tech (APT). D8 vs. Its Competitors Establishment Labs Avanos Medical Sanara MedTech Inogen Lakeland Industries Anteris Technologies Global Jin Medical International Nutriband Milestone Scientific Alpha Pro Tech D8 (NYSE:DEH) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Do insiders & institutionals believe in DEH or ESTA? 65.4% of D8 shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 11.1% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts rate DEH or ESTA? Establishment Labs has a consensus target price of $52.40, suggesting a potential upside of 39.96%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Establishment Labs is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has better earnings and valuation, DEH or ESTA? D8 has higher earnings, but lower revenue than Establishment Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioD8N/AN/A-$9.46MN/AN/AEstablishment Labs$170.24M6.36-$78.50M-$3.10-12.08 Does the MarketBeat Community favor DEH or ESTA? Establishment Labs received 122 more outperform votes than D8 when rated by MarketBeat users. CompanyUnderperformOutperformD8N/AN/AEstablishment LabsOutperform Votes12261.93% Underperform Votes7538.07% Is DEH or ESTA more profitable? D8 has a net margin of 0.00% compared to Establishment Labs' net margin of -46.13%. D8's return on equity of 0.00% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets D8N/A N/A N/A Establishment Labs -46.13%-184.55%-24.81% Does the media prefer DEH or ESTA? In the previous week, Establishment Labs had 12 more articles in the media than D8. MarketBeat recorded 12 mentions for Establishment Labs and 0 mentions for D8. Establishment Labs' average media sentiment score of 0.71 beat D8's score of -0.73 indicating that Establishment Labs is being referred to more favorably in the news media. Company Overall Sentiment D8 Negative Establishment Labs Positive SummaryEstablishment Labs beats D8 on 9 of the 13 factors compared between the two stocks. Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DEH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$341.55M$9.16B$5.57B$19.65BDividend YieldN/A1.27%5.27%3.80%P/E RatioN/A20.5926.7534.98Price / SalesN/A44.56403.9842.66Price / CashN/A19.6738.2517.51Price / Book66.005.096.964.78Net Income-$9.46M$284.66M$3.23B$1.02B D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$7.92-9.0%N/A-2.5%$341.55MN/A0.003Gap DownESTAEstablishment Labs2.6881 of 5 stars$36.70+8.0%$55.33+50.8%-15.8%$1.06B$170.24M-14.22960News CoveragePositive NewsAnalyst ForecastAVNSAvanos Medical1.9997 of 5 stars$12.43+2.9%N/A-37.1%$574.58M$689.20M36.544,040SMTISanara MedTech1.9473 of 5 stars$29.17+0.3%$49.50+69.7%-4.2%$259.26M$91.57M-29.4660Positive NewsINGNInogen4.1952 of 5 stars$6.39+0.5%$9.50+48.7%-14.3%$171.81M$339.96M-2.841,030Positive NewsLAKELakeland Industries4.9512 of 5 stars$18.03-5.2%$27.00+49.8%-38.9%$171.48M$167.21M-200.331,800Trending NewsEarnings ReportAVRAnteris Technologies GlobalN/A$4.47-3.5%$16.50+269.1%N/A$161.20M$2.71M0.00138Lockup ExpirationGap UpZJYLJin Medical InternationalN/A$0.78-2.5%N/A-74.2%$122.17M$23.50M0.00245News CoverageShort Interest ↓Gap DownNTRBNutriband2.3068 of 5 stars$7.71-4.9%$13.00+68.6%+33.4%$86.00M$2.14M-10.8610MLSSMilestone Scientific2.2588 of 5 stars$0.92-3.6%$1.25+35.9%+22.2%$72.20M$8.61M-13.1430Short Interest ↑APTAlpha Pro Tech0.9489 of 5 stars$4.86-3.0%N/A-6.7%$52.80M$58.18M13.14120 Related Companies and Tools Related Companies ESTA Competitors AVNS Competitors SMTI Competitors INGN Competitors LAKE Competitors AVR Competitors ZJYL Competitors NTRB Competitors MLSS Competitors APT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DEH) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.